Call our 24 hours, seven days a week helpline at 800.272.3900

24/7 Helpline 800.272.3900
Houston & Southeast Texas
Change Location

Historic Advances in the Fight to End Alzheimer’s by Texas State Legislature

Historic Advances in the Fight to End Alzheimer’s by Texas State Legislature
Share or Print this page
Share or Print this page
June 3, 2019
Media Line:
Share or Print this page
CONTACT: JJ Lassberg, Director Communications – Texas, 713.314.1313,

Historic Advances in the Fight to End Alzheimer’s by Texas State Legislature

86th Texas Legislature makes giant strides for Texans dealing with Alzheimer’s Disease and other dementia.

(Monday, June 3, 2019 - Austin, TX) Alzheimer’s disease is the most expensive disease in America, costing the country more than heart disease and cancer. The escalating Alzheimer’s epidemic has profound implications on individuals as well as state and federal governments. Texas ranks 4th in the number of Alzheimer’s cases and 2nd in the number of Alzheimer’s deaths in the United States. Legislators during this, the 86th, session demonstrated their commitment to strengthen Texas’s response to the serious public health crisis of Alzheimer’s disease. Numerous bills focused on dementia were considered during the state legislative session. The Alzheimer’s Association championed for and is thrilled to announce the passing of three historic advances in the fight to end Alzheimer’s. 

The 2020-2021 State Budget passed with an additional investment of $1 million for The Texas Department of State Health Services’ Alzheimer’s Disease Program. The Alzheimer’s Disease Program (ADP) provides information and resources to improve care and support for persons with the disease and their caregivers. With these additional and necessary funds, the ADP will have the capacity to provide educational resources for physicians and healthcare professional about the value of early detection and accurate diagnosis; increase public education about brain health and dementia risk reduction, and; maintain Alzheimer’s data in the state. By comparison, Florida invests $26 million annually in similar programs, while Georgia invests $4.1 million. Texas Alzheimer’s Association advocates are proud to see the state join in the ranks of other states demonstrating a clear commitment to address Alzheimer’s disease. 

“I am proud that the Texas Legislature recognizes the need for more investment in the Alzheimer’s Disease Program,” said Representative John Zerwas, M.D, chair of the House Appropriations Committee. “We must equip Texas physicians with the tools to help patients and their caregivers.”

In addition to the historic increase in funding, the Alzheimer’s State Plan bill (S.B. 999 Campbell /H.B. 1915 Zerwas) has been signed into law. The Texas State Alzheimer's plan will explore the current impact of Alzheimer's disease in the state and outline what steps the state and necessary stakeholders must take over the next five years to improve services and support for people with the disease and their families. Senate Bill 999 by Senator Dr. Campbell of New Braunfels and its companion bill, House Bill 1915, by Representative Dr. Zerwas of Richmond, requires Department of State Health Services to coordinate the development and implementation of a five year state plan on Alzheimer's disease and related dementias. 

“I advocate not only for myself, but the 390,000 Texans currently living with Alzheimer’s,” says Debbie Waskow of Bryan, TX who is in the early stages of the disease. Waskow serves on the Alzheimer’s Association National Early Stage Advisory Group and illustrated a good measure of courage this March when she travelled to the state capitol building to stand with over 150 other Texans advocating for legislation to address the growing threat the disease poses. “We were one of the first states to have a plan to address Alzheimer’s, but our plan was outdated. I am so excited to know we will now have a regularly updated state plan that continues to improve support and services for people with Alzheimer’s and their caregivers.”

Finally, a dementia training bill (H.B. 3428 Capriglione) was passed into law, requiring dementia training for Adult Protective Services and certain Area Agency on Aging workers. H.B. 3428 will help reduce elder abuse and neglect, increase the rate of reporting, and improve understanding of how cognitive impairment may affect screening, investigation, and service planning. H.B. 3824 by Representative Giovanni Capriglione (District 98 - Southlake) requires an initial 4 hours of dementia training and 2 hours of continuing education annually for Adult Protective Service employees and certain Area Agency on Aging workers. This bill will help to ensure that the workforce is adequately trained in providing care and support to the dementia community. 

“Alzheimer’s is a triple threat--with no way to prevent, treat, or cure the disease,” says Melissa Sanchez, Texas Public Policy Director for the Alzheimer’s Association. “Until we find a cure for this devastating disease, support for those living with the disease and their caregivers must remain a priority in our state. This increased investment in Alzheimer’s care and support is a big win for the 390,000 Texans living with Alzheimer's disease and the 1.4 million caregivers who provide over $20.5 billion in unpaid care. We greatly appreciate the leadership of all our bill sponsors this session and the overwhelming support we received from the legislature.”

Alzheimer's Association

The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia.™ For more information, visit or call the 24/7 Helpline at 800.272.3900.

Keep Up With Alzheimer’s News and Events

The first survivor of Alzheimer's is out there, but we won't get there without you.

Donate Now

Learn how Alzheimer’s disease affects the brain.

Take the Brain Tour

Don't just hope for a cure. Help us find one. Volunteer for a
clinical trial.

Learn More